VSee Health 3Q 2026: Revenue $1.5M, EPS ($3.88) — 10-Q Summary

VSee Health reported 3Q 2026 revenue of $1.5M, down 35% YoY, and a net loss of $2.85M, widened from $289.75K. EPS was ($3.88). The decline was driven by a shift to lower-margin teleradiology and contract expirations in Tele-ICU and Virtual Neuro services.

Original reporting
Published Nov 17, 2026, 11:01 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 11:13 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
VSee Health 3Q 2026: Revenue $1.5M, EPS ($3.88) — 10-Q Summary — source image
Decision brief

The 30-second read

$VSEEBearishMed
01

Why it matters

The key trading takeaway is that the quarter’s profitability deterioration is attributed to a shift toward lower-margin teleradiology and the expiration of specific Neuro ICU and inpatient contracts, which can reset expectations for future gross margin and revenue trajectory.

02

Market read

For traders, the disclosed quarter metrics and stated drivers (mix shift and contract expirations) are actionable for reassessing near-term revenue and margin expectations.

03

What to watch

The summary does not quantify pipeline, renewal timing, or cost actions; traders may be over-weighting the gross margin drop without seeing whether teleradiology margins are improving or stabilizing.

Relevance 6/10Novelty 6/10Timing: after-hours/filing-day read-through from the Nov. 16, 2026 10-Q

Background

The article is a brief 10-Q summary for VSee Health’s 3Q 2026 results, emphasizing revenue decline, net loss widening, and gross margin compression tied to service mix and contract expirations.

Company-level read

Ticker impact

$VSEEBearishMedium confidence
Context

VSee Health reported 3Q 2026 revenue of $1.5M, down 35.5% YoY, with gross margin falling to 21% from 48% due to mix shift.

Expected impact

Likely downside pressure as investors reprice the durability of gross margin and the revenue base after contract expirations.

Evidence & confidence

The filing summary provides concrete quarter metrics (revenue, net loss, EPS, gross margin) and explains the drivers (contract expirations and service mix), which typically matter for near-term valuation and expectations.

Market effects

Highlights margin sensitivity in telehealth services to contract renewals and service mix, which can affect sentiment toward similar providers.

No specific regional market linkage stated beyond US contract expirations.

Limited, as the disclosure is company-specific and not tied to global macro or cross-border demand.

Counterpoint

The revenue decline is partly explained by specific contract expirations and non-recurring insurance billings, so results may be less indicative of underlying unit economics if new contracts replace the lost revenue.

Key entities

  • VSee Health, Inc.

    Telehealth services provider reporting 3Q 2026 revenue decline, widening net loss, and gross margin compression in its 10-Q summary.

Related articles

$VSEEMedAI 8/10

VSee Health Signs LOI for Healthcare Platform Acquisition Target With Over $35 Million in Annualized Revenue

VSee Health (NASDAQ:VSEE) said it signed a non-binding letter of intent to acquire healthcare technology and operating assets for a vertically integrated healthcare commerce platform. VSee estimates the deal value at about $42 million, with target annualized revenue over $35 million and about $7 million EBITDA, unaudited. Closing depends on due diligence, definitive agreements, and approvals.

$VSEEMedAI 8/10

VSee Health to Acquire $35M Healthcare Commerce Platform

VSee Health, Inc. signed a non-binding LOI to acquire healthcare technology and operating assets valued at about $42 million. The target supports a clinic-based wellness commerce platform with an unaudited annual revenue run rate over $35 million and about $7 million in EBITDA. VSee says it would integrate ordering and payment workflows into its API virtual care platform, subject to due diligence and approvals.

$VSEEMed

VSee Health: VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized Revenue and Mo

VSee Health (NASDAQ:VSEE) said it entered a non-binding letter of intent to acquire certain healthcare technology and operating assets for a vertically integrated healthcare commerce platform. The target assets have an unaudited run rate above $35 million and EBITDA around $7 million. VSee expects a quick close without initial shareholder dilution, subject to due diligence and definitive agreements.

$VSEEMed

VSEE HEALTH, INC. (VSEE): Completion of Acquisition or Disposition of Assets

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-99.1 3 vseeex99-1.htm EXHIBIT 99.1 Exhibit 99.1 VSEE HEALTH, INC. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS On May 31, 2026, VSee Health, Inc., a Delaware corporation (the “Company”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) with

$DISHighAI 9/10

Why is Walt Disney stock climbing today?

Walt Disney (DIS) stock rose 2.4% after reporting Q4 revenue of $25.9B (+16% YoY), operating income of $5.0B (+43%), and adjusted EPS of $1.77, beating estimates. The company raised its dividend by 33% and announced $3B in cost cuts by 2029, with guidance for double-digit EPS growth in 2027. Disney Experiences reported record revenue and income. Shares hit a 52-week high of $122.72 despite early volatility and a weak broader market.